Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (11-20 of 246) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Flashback Foreword: IFL/FOLFOX/IROX in Advanced Colorectal Cancer and FOLFIRI and FOLFOX6 in Colorectal CancerAlan P Venook
Cancer Chemotherapy and Pharmacology|August 17, 2004
Key research issues in the management of hepatocellular carcinomaAlan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Advances in Adjuvant Therapy for Colon Cancer: P value or Practical ValueAlan P Venook
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibitionAlan P Venook
JCO Oncology Practice|April 4, 2023
Neoadjuvant Immunotherapy for Colorectal Cancer: Too Good to Be True?Alan P Venook
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Targeted therapy in colorectal cancerSupriya Rajpal, Alan P Venook
Cancer|August 22, 2019
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancerSorbarikor Piawah, Alan P Venook
Current Oncology Reports|April 2, 2009
Drug development in advanced colorectal cancer: challenges and opportunitiesRobin Kelley, Alan P Venook
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal CancerAxel Grothey, Alan P Venook
Oncology (Williston Park, N.Y.)|November 28, 2017
The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal CancerCarling Ursem, Alan P Venook
Pageof 25

Showing results (11-20 of 246) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Flashback Foreword: IFL/FOLFOX/IROX in Advanced Colorectal Cancer and FOLFIRI and FOLFOX6 in Colorectal CancerAlan P Venook
Cancer Chemotherapy and Pharmacology|August 17, 2004
Key research issues in the management of hepatocellular carcinomaAlan P Venook
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Advances in Adjuvant Therapy for Colon Cancer: P value or Practical ValueAlan P Venook
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibitionAlan P Venook
JCO Oncology Practice|April 4, 2023
Neoadjuvant Immunotherapy for Colorectal Cancer: Too Good to Be True?Alan P Venook
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Targeted therapy in colorectal cancerSupriya Rajpal, Alan P Venook
Cancer|August 22, 2019
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancerSorbarikor Piawah, Alan P Venook
Current Oncology Reports|April 2, 2009
Drug development in advanced colorectal cancer: challenges and opportunitiesRobin Kelley, Alan P Venook
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal CancerAxel Grothey, Alan P Venook
Oncology (Williston Park, N.Y.)|November 28, 2017
The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal CancerCarling Ursem, Alan P Venook
Pageof 25